PIK3CA and cancer: However, considering that the investigation of small molecule inhibitors of the PI3K signaling network is a promising area of oncology drug development, in the next few years these patients may well benefit from the results of completed and ongoing clinical trials on PI3K inhibitors in cancer therapy.